Olmesartan-associated enteropathy: New insights on the natural history? Report of two cases

Annalisa Schiepatti, Federico Biagi, Davide Cumetti, Ombretta Luinetti, Aurelio Sonzogni, Amedeo Mugellini, Gino R. Corazza

Research output: Contribution to journalArticlepeer-review


Introduction: The association between olmesartan and an enteropathy histologically indistinguishable from untreated celiac disease has recently been described. However, pathogenetic mechanisms leading to villous atrophy, prevalence, natural history and genetic background of this condition have not yet been defined. Patients: We describe here two cases of olmesartan-associated enteropathy and discuss some aspects of the natural history of this condition. Results: In both patients, an infectious episode seems to have triggered the severe malabsorption syndrome which led them to hospitalization. High titer positive antinuclear antibodies with homogeneous pattern were found. Conclusions: Our reports add to a growing body of evidence suggesting that olmesartan-associated enteropathy should be considered in the presence of villous atrophy and negative celiac serology and in the diagnostic algorithm of non-responsive celiac disease.

Original languageEnglish
Pages (from-to)152-156
Number of pages5
JournalScandinavian Journal of Gastroenterology
Issue number2
Publication statusPublished - Feb 1 2016


  • celiac disease
  • enteropathy
  • olmesartan
  • villous atrophy

ASJC Scopus subject areas

  • Gastroenterology


Dive into the research topics of 'Olmesartan-associated enteropathy: New insights on the natural history? Report of two cases'. Together they form a unique fingerprint.

Cite this